- Home
- CURR vs HLVX Comparison
CURR vs HLVX Comparison
Compare CURR & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURR
- HLVX
- Stock Information
- Founded
- CURR 2013
- HLVX 2020
- Country
- CURR Singapore
- HLVX United States
- Employees
- CURR N/A
- HLVX N/A
- Industry
- CURR Business Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- CURR Consumer Discretionary
- HLVX Health Care
- Exchange
- CURR Nasdaq
- HLVX Nasdaq
- Market Cap
- CURR 74.0M
- HLVX 83.7M
- IPO Year
- CURR N/A
- HLVX 2022
- Fundamental
- Price
- CURR $0.43
- HLVX $1.86
- Analyst Decision
- CURR Strong Buy
- HLVX Hold
- Analyst Count
- CURR 1
- HLVX 5
- Target Price
- CURR $3.50
- HLVX $2.33
- AVG Volume (30 Days)
- CURR 2.5M
- HLVX 204.2K
- Earning Date
- CURR 08-11-2025
- HLVX 08-07-2025
- Dividend Yield
- CURR N/A
- HLVX N/A
- EPS Growth
- CURR N/A
- HLVX N/A
- EPS
- CURR N/A
- HLVX N/A
- Revenue
- CURR $43,386,858.00
- HLVX N/A
- Revenue This Year
- CURR N/A
- HLVX N/A
- Revenue Next Year
- CURR $21.53
- HLVX N/A
- P/E Ratio
- CURR N/A
- HLVX N/A
- Revenue Growth
- CURR N/A
- HLVX N/A
- 52 Week Low
- CURR $0.33
- HLVX $1.34
- 52 Week High
- CURR $7.08
- HLVX $15.25
- Technical
- Relative Strength Index (RSI)
- CURR N/A
- HLVX 52.21
- Support Level
- CURR N/A
- HLVX $1.82
- Resistance Level
- CURR N/A
- HLVX $2.07
- Average True Range (ATR)
- CURR 0.00
- HLVX 0.07
- MACD
- CURR 0.00
- HLVX -0.01
- Stochastic Oscillator
- CURR 0.00
- HLVX 41.18
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.